| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/27/2005 | CN1646490A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms I, VIII and IX |
| 07/27/2005 | CN1646489A Delta1-pyrrolines and their use as pestcidal |
| 07/27/2005 | CN1646121A Methods for modulating phototoxicity |
| 07/27/2005 | CN1212327C Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts |
| 07/26/2005 | US6921765 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 07/26/2005 | US6921758 Amino acid derivatives |
| 07/26/2005 | CA2256609C 5-aroylpyrrol-2-ylmethylarene derivatives as inhibitors of prostaglandin g/h synthase |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/26/2005 | CA2139045C Alkoxymethylation of pyrroles |
| 07/21/2005 | WO2005066159A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005066135A2 Pyrrole and pyrazole daao inhibitors |
| 07/21/2005 | WO2005066125A1 Cis-alkoxyspiro-substituted tetramic acid derivatives |
| 07/21/2005 | WO2005066124A1 Method for producing pyrrolidine derivative |
| 07/21/2005 | WO2005066123A1 Protease inhibitors |
| 07/21/2005 | WO2005066122A2 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| 07/21/2005 | WO2005066121A2 Multifunctional amine capture agents |
| 07/21/2005 | WO2005065778A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005065370A2 Soluble polymers as amine capture agents and methods |
| 07/21/2005 | WO2005065050A2 Bicyclic compound |
| 07/21/2005 | US20050159622 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative |
| 07/21/2005 | US20050159585 Forming acyl azide function on acid group of amino acid derivative, then transforming to isocyanate |
| 07/21/2005 | US20050159584 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers |
| 07/21/2005 | US20050159560 Reacting a di- or polyamine with an unsaturated ester and then reacting the resultant product with a maleimide, useful as reactive component for polyisocyanates in two-component polyurethane coating formulation |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159423 Antibacterial compounds |
| 07/21/2005 | US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 07/21/2005 | US20050159363 Selective neuronal nitric oxide synthase inhibitors |
| 07/21/2005 | US20050159341 Scaffolded maleimide clusters for multivalent peptide assembly |
| 07/21/2005 | US20050158785 Non-peptide compounds 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; for use in bioassay, fluorescent quantitative analysis; control of gene expression, treatment/prevention of cancer |
| 07/21/2005 | US20050158708 High thoughput assay; rapid profiling; proteomics |
| 07/21/2005 | DE10358814A1 Prolinylarylacetamide Prolinylarylacetamide |
| 07/21/2005 | DE102004005317A1 Optisch aktive Carboxamide Optically active carboxamides |
| 07/21/2005 | CA2552737A1 Cis-alkoxyspiro-substituted tetramic acid derivatives |
| 07/21/2005 | CA2552726A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2552713A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2551952A1 Pyrrole and pyrazole daao inhibitors |
| 07/21/2005 | CA2550515A1 Protease inhibitors |
| 07/20/2005 | EP1555313A2 Method for the identification of hydroxyphenylpyruvate dioxygenase inhibitors |
| 07/20/2005 | EP1554274A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1554242A1 Watersoluble prodrugs of propofol |
| 07/20/2005 | EP1554239A2 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 07/20/2005 | EP1268396B1 Diphenyl ether compounds useful in therapy |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1056717B1 Arylphenyl-substituted cyclic keto-enols |
| 07/20/2005 | CN1643587A Squarylium dyes as a light-absorbing compound in the information layer of optical data carriers |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642906A Novel arylamidine derivative or salt thereof |
| 07/20/2005 | CN1642555A Statin therapy for enhancing cognitive maintenance |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642535A Tuberculosis treatment using pleuromutilin derivatives |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/20/2005 | CN1211361C Fused-ring carboxylic acid derivatives |
| 07/20/2005 | CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 07/19/2005 | US6919456 For the direct catalytic asymmetric aldol reaction of aldehydes with donor molecules selected from ketones and nitroalkyl compounds |
| 07/19/2005 | US6919368 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919179 Generating labeled proteins; obtain nucleotide sequences, incubate with cell free translation system, recover labeled protein |
| 07/14/2005 | WO2005064349A2 Detection cartridges, modules, systems and methods |
| 07/14/2005 | WO2005063741A1 Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrol-1-yl]-ethyl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| 07/14/2005 | WO2005063729A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063692A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 07/14/2005 | WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR |
| 07/14/2005 | WO2005037785A3 Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/14/2005 | WO2004113277A8 Methods and compositions for treating amyloid-related diseases |
| 07/14/2005 | WO2004099331A3 Imide-linked maleimide and polymaleimide compounds |
| 07/14/2005 | WO2004050618A8 Crystalline form f of atorvastatin hemi-calcium salt |
| 07/14/2005 | WO2003022007A8 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 07/14/2005 | US20050155087 Method of screening compounds |
| 07/14/2005 | US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154062 Substituted chiral allosteric hemoglobin modifiers |
| 07/14/2005 | US20050154056 Inhibitors of HCV NS5B polymerase |
| 07/14/2005 | US20050154043 Heterocyclic compounds useful as growth hormone secretagogues |
| 07/14/2005 | US20050154042 N-alkyl pyrroles as HMG-CoA reductase inhibitors |
| 07/14/2005 | US20050154019 Substituted cyclic amine metalloprotease inhibitors |
| 07/14/2005 | US20050154011 such as S)-3-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester, used in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes |
| 07/14/2005 | US20050153973 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; enzyme inhibitors; diabetes |
| 07/14/2005 | US20050153903 Inhibitors of enzymes for treatment of Aids or making intermediates |
| 07/14/2005 | CA2552208A1 Detection cartridges, modules, systems and methods |
| 07/14/2005 | CA2551610A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 07/14/2005 | CA2551549A1 Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrol-1-yl]-ethyl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1551801A1 Novel gamma-lactams as beta-secretase inhibitors |
| 07/13/2005 | EP1551800A1 Pyrrolidine derivatives for use in treating hepatitis c virus infection |
| 07/13/2005 | EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 07/13/2005 | EP1178969B1 Gastrin and cholecystokinin receptor ligands |
| 07/13/2005 | EP1171443B1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors |
| 07/13/2005 | CN1639155A Pyrrolidine oxadiazole- and thiadiazole derivatives |